Clinical Trial

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

Name: Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients — clinical trial record (NCT06956144)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy of targeted CAIX-specific probe PET imaging in the diagnosis and staging of kidney cancer, as well as to assess its role in prognosis prediction and treatment evaluation for kidney cancer.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-25.

Trial Details

NCT Number	NCT06956144
Lead Sponsor	The First Affiliated Hospital of Xiamen University
Conditions	Tumor, Carbonic Anhydrase IX
Enrollment	113 participants
Start Date	2025-05-09
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-29